Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis.

Item

http://www.wikidata.org/entity/Q36320021

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Challenges of developing a car ...... nts with rheumatoid arthritis.

@ast

Challenges of developing a car ...... nts with rheumatoid arthritis.

@en

type

Item

label

Challenges of developing a car ...... nts with rheumatoid arthritis.

@ast

Challenges of developing a car ...... nts with rheumatoid arthritis.

@en

prefLabel

Challenges of developing a car ...... nts with rheumatoid arthritis.

@ast

Challenges of developing a car ...... nts with rheumatoid arthritis.

@en

P1476

Challenges of developing a car ...... nts with rheumatoid arthritis.

@en

P2093

A Trans-Atlantic Cardiovascular Risk Consortium for Rheumatoid Arthritis (ATACC-RA)

http://www.w3.org/2001/XMLSchema#string

Anne Grete Semb

http://www.w3.org/2001/XMLSchema#string

Cynthia S Crowson

http://www.w3.org/2001/XMLSchema#string

George D Kitas

http://www.w3.org/2001/XMLSchema#string

Piet L C M van Riel

http://www.w3.org/2001/XMLSchema#string

Sherine E Gabriel

http://www.w3.org/2001/XMLSchema#string

Silvia Rollefstad

http://www.w3.org/2001/XMLSchema#string

P2860

Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score.

Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data

THE LASSO METHOD FOR VARIABLE SELECTION IN THE COX MODEL

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

Inconsistent treatment with disease-modifying antirheumatic drugs: a longitudinal data analysis

A calibration hierarchy for risk models was defined: from utopia to empirical data.

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity.

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

P304

e0174656

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0174656

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Silvia Rollefstad

P577

2017-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28334012

http://www.w3.org/2001/XMLSchema#string

P932

5363942

http://www.w3.org/2001/XMLSchema#string